Progestogens in the treatment of carcinoma of the endometrium.
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000401:mortality; D000463:Algestone Acetophenide / Q000627:therapeutic use; D004717:Endometrium; D005260:Female; D006801:Humans; D006908:Hydroxyprogesterones / Q000008:administration & dosage / Q000627:therapeutic use*; D007273:Injections, Intramuscular; D008175:Lung Neoplasms; D009362:Neoplasm Metastasis; D011372:Progestins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000401:mortality
D006908:Hydroxyprogesterones; D011372:Progestins; D000463:Algestone Acetophenide